NeoGenomics (NEO)
(Delayed Data from NSDQ)
$14.96 USD
-0.84 (-5.32%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $14.95 -0.01 (-0.07%) 5:42 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for NeoGenomics, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 415 | 438 | 515 | 296 | 173 |
Receivables | 131 | 120 | 112 | 107 | 94 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 24 | 24 | 23 | 30 | 14 |
Other Current Assets | 26 | 23 | 31 | 16 | 9 |
Total Current Assets | 597 | 605 | 682 | 449 | 291 |
Net Property & Equipment | 92 | 103 | 109 | 86 | 64 |
Investments & Advances | 0 | 0 | 0 | 30 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 896 | 931 | 969 | 332 | 325 |
Deposits & Other Assets | 5 | 5 | 7 | 47 | 3 |
Total Assets | 1,681 | 1,740 | 1,870 | 988 | 710 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 20 | 21 | 18 | 25 | 20 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 5 |
Current Portion Capital Leases | 0 | 0 | 1 | 3 | 5 |
Accrued Expenses | 68 | 55 | 56 | 36 | 29 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 8 | 5 | 4 | 2 |
Total Current Liabilities | 96 | 90 | 87 | 73 | 64 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 24 | 35 | 55 | 5 | 16 |
Convertible Debt | 538 | 535 | 532 | 168 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 92 |
Non-Current Capital Leases | 0 | 0 | 0 | 1 | 3 |
Other Non-Current Liabilities | 13 | 13 | 14 | 4 | 4 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 740 | 742 | 762 | 294 | 202 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,190 | 1,161 | 1,124 | 701 | 520 |
Retained Earnings | -247 | -159 | -15 | -7 | -11 |
Other Equity | -2 | -4 | -1 | 0 | -2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 942 | 998 | 1,108 | 694 | 507 |
Total Liabilities & Shareholder's Equity | 1,681 | 1,740 | 1,870 | 988 | 710 |
Total Common Equity | 942 | 998 | 1,108 | 694 | 507 |
Shares Outstanding | 127.40 | 126.30 | 123.10 | 111.00 | 104.40 |
Book Value Per Share | 7.39 | 7.90 | 9.00 | 6.25 | 4.86 |
Fiscal Year End for NeoGenomics, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 388 | 385 | 415 | 402 | 409 |
Receivables | 147 | 140 | 131 | 133 | 125 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 23 | 20 | 24 | 24 | 25 |
Other Current Assets | 27 | 28 | 26 | 28 | 25 |
Total Current Assets | 584 | 574 | 597 | 587 | 585 |
Net Property & Equipment | 92 | 88 | 92 | 95 | 100 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 879 | 888 | 896 | 905 | 913 |
Deposits & Other Assets | 4 | 4 | 5 | 5 | 5 |
Total Assets | 1,643 | 1,640 | 1,681 | 1,678 | 1,695 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 17 | 18 | 20 | 17 | 18 |
Current Portion Long-Term Debt | 200 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 68 | 53 | 68 | 66 | 64 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 2 | 4 | 6 |
Total Current Liabilities | 290 | 77 | 96 | 93 | 95 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 23 | 23 | 24 | 25 | 29 |
Convertible Debt | 340 | 539 | 538 | 537 | 537 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 12 | 13 | 13 | 13 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 727 | 717 | 740 | 731 | 739 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,210 | 1,199 | 1,190 | 1,182 | 1,173 |
Retained Earnings | -293 | -274 | -247 | -233 | -214 |
Other Equity | -1 | -1 | -2 | -2 | -3 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 916 | 923 | 942 | 947 | 956 |
Total Liabilities & Shareholder's Equity | 1,643 | 1,640 | 1,681 | 1,678 | 1,695 |
Total Common Equity | 916 | 923 | 942 | 947 | 956 |
Shares Outstanding | 128.10 | 127.70 | 127.40 | 127.50 | 127.50 |
Book Value Per Share | 7.15 | 7.23 | 7.39 | 7.43 | 7.50 |